Nasal Allergy Treatment Market Insights, Research and Growth Factor till 2033

According to Future Market Insights' most recent industry report, the global Nasal Allergy Treatment Market sales was valued at roughly US$ 6.6 billion in 2022 and is expected to grow at a CAGR of 6.7% over the forecast period, reaching an anticipated worth of US$ 13.3 billion in 2033.

Although allergies are common, the causes might vary from person to person. A diagnostic test can quickly identify the allergy. According to the Journal of Family Medicine and Primary Care in 2020, the prevalence of nasal allergies among patients is significant, and there is a lack of awareness and information about them. The patient has a limited awareness of nasal allergies' causes, symptoms, effects, and therapy. Health education programmes on the topic may influence patients' knowledge of nasal allergies.

In such cases, awareness is critical, thus webinars and campaigns can help spread the word. One such example is allergy awareness week, a health-focused week founded by the charity Allergy UK and observed every year during a week chosen by the organisation. It takes place in the year 2023, from April 24 to April 30. This week is dedicated to educating people about allergies as well as helping and supporting those who suffer from allergic illnesses.

Major Players:

  • Merck KGaA
  • Johnson & Johnson
  • Allergopharma
  • Sanofi SA
  • McNeil Consumer Healthcare,
  • Genentech Inc.
  • GlaxoSmithKline PLC
  • Leti Pharma,
  • Alerpharma S.A
  • Allergan, Inc.
  • Meda Pharmaceuticals, Inc
  • Novartis International AG
  • Bausch Health Companies Inc.
  • Allergopharma
  • ALK Abello
  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Biomay AG
  • HAL Allergy Group
  • Bayer
  • AstraZeneca

Browse Detail Summary of Research Report@ https://www.futuremarketinsights.com/reports/nasal-allergy-treatment-market

Market Segments are:

By Disease Type:

  • Allergic Rhinitis
  • Seasonal Allergic Rhinitis
  • Perennial Allergic Rhinitis
  • Non-Allergic Rhinitis
  • Infectious Rhinitis

By Form:

  • Tablets/Capsules
  • Liquid
  • Creams & Lotions
  • Drops
  • Spray

By Prescription Type:

  • OTC
  • Prescription based

By Route of Administration:

  • Oral
  • Intranasal
  • Sublingual
  • Sub Cutaneous
  • Intravenous

By Treatment:

  • Antihistamines
  • Decongestants
  • Nasal Corticosteroids
  • Allergen Immunotherapy
  • Leukotriene Receptor Antagonists

By Distribution Channel:

  • Hospital Pharmacies
  • Supermarkets/Hypermarkets
  • Online Pharmacies
  • Retail Pharmacies
  • Speciality Clinics
  • Others

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more